TopiramateHyperchloraemic acidosis and pancreatitis following an off-label use of topiramate: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1787卷 / 1期

关键词：

D O I：

10.1007/s40278-020-74104-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：466 / 466

相关论文

共 50 条

[31] ImiquimodLymphoedema following off-label use: 3 case reports
Reactions Weekly, 2018, 1711 (1) : 146 - 146
[32] LinezolidMyelotoxicity and metabolic acidosis following off-label use: case report
Reactions Weekly, 2018, 1732 (1) : 231 - 231
[33] HydroxychloroquineHypoglycaemia following off-label use: 3 case reports
Reactions Weekly, 2020, 1822 (1) : 152 - 152
[34] MogamulizumabRash following off-label use: 4 case reports
Reactions Weekly, 2023, 1984 (1) : 345 - 345
[35] Lopinavir/ritonavir/tocilizumabHypertriglyceridaemia following off-label use: 2 case reports
Reactions Weekly, 2020, 1824 (1) : 180 - 180
[36] VenetoclaxDizziness and diarrhea following an off-label use of venetoclax: 2 case reports
Reactions Weekly, 2020, 1787 (1) : 477 - 477
[37] BevacizumabWorsening of hypertension and epistaxis following off-label use: 2 case reports
Reactions Weekly, 2020, 1799 (1) : 97 - 97
[38] Dibotermin-αSeroma following off-label use: 2 case reports
Reactions Weekly, 2019, 1782 (1) : 126 - 126
[39] Azithromycin/hydroxychloroquineQTc prolongation following off-label use: 2 case reports
Reactions Weekly, 2021, 1842 (1) : 83 - 83
[40] RituximabCystoid macular oedema following off-label use: 2 case reports
Reactions Weekly, 2021, 1869 (1) : 320 - 320

← 1 2 3 4 5 →